Care Program for Dementia Caregivers
(CECP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new digital program designed to support Spanish-speaking caregivers of people with dementia. The program, called the Spanish-language Caregiver-Enabled Care Program (CECP), provides personalized education, coaching, and remote monitoring through a tablet at no cost. It aims to enhance caregivers' confidence and skills in caring for their loved ones. Spanish-speaking caregivers supporting a family member with dementia may be well-suited for this trial. As an unphased trial, this study offers a unique opportunity to access innovative support tools specifically designed for Spanish-speaking caregivers.
Do I have to stop taking my current medications for this trial?
The trial does not specify whether you need to stop taking your current medications. It focuses on a nonmedical digital health program for caregivers, so it's unlikely that medication changes are required.
What prior data suggests that this digital health intervention is safe for caregivers?
Research has shown that the Spanish-language Caregiver-Enabled Care Program (CECP) is a digital tool that avoids drugs or medical procedures, making it generally safer. The program offers personalized education, coaching, and support through a tablet. As a digital health program, it is user-friendly and has no significant safety concerns or reported issues. The goal is to enhance caregivers' skills and confidence, not to provide medical treatment, which typically ensures a high level of safety for participants.12345
Why are researchers excited about this trial?
Unlike traditional dementia care options that typically focus on the patient, the Spanish-language Caregiver-Enabled Care Program (CECP) shifts the spotlight to the caregivers themselves. This program is unique because it provides caregivers with personalized health education, proactive coaching, and remote monitoring, all delivered through a dedicated tablet. Researchers are excited about this approach because it empowers caregivers, enhancing their skills and confidence in managing their loved one's dementia, potentially leading to better outcomes for both caregivers and patients.
What evidence suggests that the Spanish-language Caregiver-Enabled Care Program (CECP) is effective for dementia caregivers?
Research has shown that the Spanish-language Caregiver-Enabled Care Program (CECP), which participants in this trial will receive, is designed to assist Spanish-speaking caregivers of people with dementia by offering personalized support and education. This program aims to enhance caregivers' knowledge, skills, and confidence in managing daily challenges. Although specific results from past studies are not available, digital tools and one-on-one coaching have improved caregiver well-being and reduced stress. The CECP provides practical support by offering resources and remote monitoring through a tablet, potentially leading to better care for loved ones with dementia and improving caregivers' quality of life.12367
Who Is on the Research Team?
Dirk Soenksen
Principal Investigator
CEO
Are You a Good Fit for This Trial?
This trial is for Spanish-speaking caregivers in the U.S. who are part of a PACE or dementia support network, caring for someone with dementia. Caregivers must be adults willing to engage with a digital health program and able to read and write Spanish.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in the Spanish-language Caregiver-Enabled Care Program (CECP) for 6 months, which includes personalized education, proactive coaching, and remote monitoring via a dedicated tablet.
Follow-up
Participants are monitored for engagement and outcomes such as loneliness, caregiver activation, and health status.
What Are the Treatments Tested in This Trial?
Interventions
- Spanish-language Caregiver-Enabled Care Program (CECP)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ceresti Health, Inc.
Lead Sponsor
National Institute on Aging (NIA)
Collaborator